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Abstract: Several species of Croton have been described with biological activities, 
mainly due to diterpenes, alkaloids and/or other secondary metabolites. These activities 
account for the traditional use of Croton species to treat certain diseases in South America, 
Asia and Western Africa. The crude methanol extracts obtained from leaves and steam 
bark of Croton dichrous Müll. Arg., C. erythroxyloides Baill., C. myrianthus Müll. Arg. 
and C. splendidus Mart. ex Colla were tested for antiproliferative activity against ten 
human cancer cell lines. Chemical analyses of all extracts were carried out by GC/MS 
and HPLC/MS/MS. The leaf extract obtained from C. erythroxyloides showed potent 
activity against PC-3 (prostate) and OVCAR-3 (ovary) cell lines. Lupeol is suggested to 
be involved in such activity. Tiliroside, an acyl-glycosilated fl avonoid ubiquitous in all 
tested extracts, seems to play an important role in the observed moderate activity of most 
extracts against the leukemia K562 cell lineage. 
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Introduction
 Several species of Euphorbiaceae are known in 
many parts of the world for their toxic and/or medicinal 
properties (Salatino et al., 2007). Such diversity of effects 
is a refl ection of the variety of secondary metabolites 
which have already been described for this family. 
 Croton L. is one of the giant genera of 
angiosperms, comprising over 1200 species of herbs, 
shrubs, trees and occasionally vines. Recent studies have 
estimated that approximately two-thirds of the Croton 
species occur in the New World, the other third being 
distributed across the Old World (van Ee et al., 2011). 
It is the second largest genus in Euphorbiaceae, with 
various species used in folk medicine in many regions of 
the world. 
 Hypoglycemic, hypolipidemic, anti-estrogenic, 
anti-tumor and trypanocidal effects have been ascribed 
to the trans-terpenoid dehydrocrotonin obtained from 
C. cajucara (Maciel et al., 2002; Campos et al., 2010). 
Antiulcerogenic effect in gastric lesion of the hydroalcoholic 
extract of C. campestris leaves has been demonstrated in 
laboratory assays with mice (Júnior et al. 2013). Both latex 
and the alkaloid taspine, isolated from C. lechleri, show 
cytotoxic activity (Montopoli et al., 2012), and plaunotol, 
an open-chain diterpene found in Croton species, acts in 
synergism with common drugs against Helicobacter pylori 
(peptic ulcer-causing bacteria) (Sasaki et al., 2007) and as 
antiangiogenic (Kawai et al., 2005).
 The biological activities of these compounds 
account for the traditional use of Croton species to treat 
certain diseases in South America, Asia and Western Africa 
(Sampson et al., 2000). Cancer is a disease recognized 
by several hallmarks, one of the main ones being the 
proliferation of atypical cells (Mantovani, 2009). According 
to the World Health Organization, cancer is a leading 
cause of death worldwide. The organization estimates that 
84 million people will die from cancer between 2005 and 
2015 (WHO, 2007).
 The potential use of natural products against 
cancer has been recognized since 1950 by the National 
Cancer Institute (USA) (Cragg & Newman, 2005). Some 
important drugs currently available were discovered by 
the investigation of secondary metabolites of plants, some 
examples being taxol, extracted from the stem of Taxus 
brevifolia, Taxaceae (Wani et al., 1971) and vincristine, 
an alkaloid from the roots of Catharanthus roseus, 
Apocynaceae (Johnson et al., 1963).
 The antiproliferative activity of crude extracts 
of some species of Croton have already been described. 
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Stem bark essential oil obtained from C. lechleri showed 
mutagen-protective efficacy (Rossi et al., 2013) and crude 
extracts of stems of C. cajucara (Maciel et al., 2007) 
exert antitumor activity against the K562 leukemic cell 
line. The dicloromethane extract of C. macrobothrys 
leaves exhibited antiproliferative activity against several 
cell lines, in particular on NCI-H460 (lung) and K562 
(leukemia) (Motta et al., 2011). 
 In this study, we investigated the antiproliferative 
activity of methanol extracts from four Brazilian native 
species of Croton, and suggest compounds involved in 
the observed effects. For this, ten human tumor cell lines 
commonly investigated were used: 786-0 (kidney), HT-29 
(colon), K562 (leukemia), NCI-ADR/RES (drug resistant 
ovary), NCI-H460 (lung), MCF-7 (mammary), PC-3 
(prostate), OVCAR-3 (ovary), U251 (glioma), UACC-62 
(melanoma).
Materials and Methods
Plant material 
 Samples of Croton dichrous Müll. Arg. 
(Cordeiro 3066, Campos do Jordão-SP), C. 
erythroxyloides Baill. (Cordeiro 3067, Campos do 
Jordão-SP), C. myrianthus Müll. Arg. (Lima 296, 
Cambará do Sul-RS) and C. splendidus Mart. ex Colla 
(Cordeiro 3041, Santa Barbara-MG) were collected and 
voucher specimens were deposited in the Herbarium 
of the Institute of Botany - São Paulo (SP), and in the 
Herbarium of the Institute of Biosciences, São Paulo 
(SPF).
Crude extract preparation and analysis
 Dried leaves and stems (2 g) were powdered 
separately, and extracted with methanol under reflux for 
1 h (three times). The extracts were pooled and dried 
under reduced pressure. An aliquot of 10 mg of the dried 
extract was used for the antiproliferative tests.The samples 
were submmited to HPLC, HPLC/MS/MS and GC/MS 
analysis.
HPLC and HPLC/MS/MS
 The methanol extracts were analysed by HPLC-
DAD (Agilent - HP 1090 II) using a reverse phase column 
(Zorbax C18 - 4.6 x 250 mm, 5 μm) and a gradient of 0.1% 
acetic acid (solvent A) and acetonitrile (solvent B) with the 
following program: 0-5 min 12% of B; 5-8 min 12% - 20% 
of B; 8-28 min 20% of B; 28-38 min 20% - 50% of B; 38-48 
min 50% - 65% of B. The solvent flux was 0.5 mL.min-1, the 
column temperature was 40 oC and the detection at λ=352 
nm (Motta et al., 2009). Samples were also analysed by 
HPLC/MS/MS (Shimadzu M10AVP/Esquire 3000 Plus, 
Bruker Daltonics). The analysis was developed under the 
same conditions, but the solvent flux of 90 μL.min-1. The 
mass spectrometer parameters involved skimmer voltage 
at 4000 V, nebulizer at 27 psi, dry gas at 320 oC with flux 
of 7,0 L/min. Major compounds identification used MS 
information and the available private library constructed in 
the Phytochemistry Lab, Department of Botany, University 
of São Paulo.
GC/MS analysis
 The methanol extracts were submitted to GC/
MS (Agilent GC/MS 6859/5975B) employing a DB-5 HT 
column (30 m x 0,25 mm x 0,25 μm) and He as carrier gas 
at 1.2 mL.min-1. The injector temperature was 250 °C, and 
the heating column program was: 150 °C, 1 min, heating 
ramp of 6 °C.min-1 until 310 °C, keeping this temperature 
for 3 min. The samples were analysed in the splitless mode. 
The temperatures of the MS source and the quadrupole 
were 230 and 150 °C, respectively. The ions were detected 
in the positive mode, with 2.7 scan.seg-1, in a mass range 
of 40-450 a.m.u. The electron multiplier voltage was 
adjusted to 70 eV. The compounds identification followed 
comparison with NIST 05 MS Library Bundle (Agilent).
Cell cultures
 Ten human tumor cell lines were used [786-0 
(kidney), HT-29 (colon), K562 (leukemia), NCI-ADR/
RES (drug resistant ovary), NCI-H460 (lung), MCF-7 
(mammary), PC-3 (prostate), OVCAR-3 (ovary), U251 
(glioma), UACC-62 (melanoma)] and were kindly provided 
by National Cancer Institute at Frederick MA-USA (NCI). 
Also a non-tumor cell line (VERO, renal, green monkey) 
was used. Stock cell cultures were grown in medium 
containing RPMI 1640, supplemented with 5% of fetal 
bovine serum. Experimental cultures were supplemented 
also with peniciline:streptomicine (10 μg/mL:10 UI/mL). 
Antiproliferative assay
 Cells (100 μL cells/well, inoculation density 
from 3-6 x104 cell/mL) in 96-well plates were exposed to 
various sample concentrations (0.25 to 250 μg/mL, 100 
μL/well) in DMSO/RPMI 1640 at 37 oC, 5% of CO2 in air 
for 48 h. Final DMSO concentration (0.2%) did not affect 
cell viability. Cells, before (T0) and after 48 h exposition 
(T1), were then fixed with 50% trichloroacetic acid and 
cell proliferation was determined by spectrophotometric 
quantification of cellular protein content at 540 nm, using 
the sulforhodamine B assay. Doxorubicin (DOX; 0.025, 25 
μg/mL) was used as positive control. Three measurements 
were obtained at the beginning of incubation (time zero, T0) 
and 48 h post-incubation for compound-free (T1) and tested 
(T) cells. Cell proliferation was determined according to 
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the equation 100 x [(T-T0) / (T1-T0)], for T0 < T ≤ T1, and 
100 x [(T-T0)/T0], for T ≤ T0 and a concentration-response 
curve for each cell line was plotted using software Origin 
7.5 (OriginLab Corporation) (Monks et al., 1991).
Data analysis
 Using the concentration-response curve for 
each cell line, the GI50 (concentration causing 50% 
growth inhibition) (Shoemaker, 2006) of each cell line 
was determined by non-linear regression analysis, using 
software Origin 7.5. The average activity (mean of log 
GI50) of the analysed extracts was also determined using 
MS Excel software (Fouche et al., 2008). The average 
activity is a parameter used by the National Cancer Institute 
to classify the test-extract as: I: inactive (mean of log GI50 
>1.5); W: week activity (mean of log GI50>1.1-1.5); M: 
moderate activity (mean of log GI50>0-1.1); and P: potent 
activity (mean of log GI50<0).
Results and Discussion
 Table 1 presents the results of antiproliferative 
activity obtained with the methanol extracts of Croton 
dichrous Müll. Arg., C. erythroxyloides Baill., C. 
myrianthus Müll. Arg. and C. splendidus Mart. ex Colla 
against human tumor cell lines. Using the National 
Cancer Institute criteria, which means looking through 
the mean value of the logarithm of GI50 for all the tumor 
cell lines used, except the non tumor VERO, only the 
extract obtained from leaves of C. erythroxyloides showed 
moderate activity (mean of log GI50=1.00) against cancer 
cells. This extract also presented a high selectivity for PC-3 
(prostate, GI50=0.80 μg.mL-1) and OVCAR-3 (ovarian, 
GI50=0.81 μg.mL-1) cell lines. Based on the NCI criteria, 
these individual GI50 values indicate potent activity (log 
GI50<0), similar to doxorubicin, an effective drug used in 
cancer control.
 Although an excellent growth inhibiter of cancer 
cells, doxorubicin also affects the growth of non-tumor 
cells, for example, the ones from the VERO cell line (Table 
1). In this regard, all assayed Croton extracts seem to be 
safer than doxorubicin, since toxicity to healthy cells had 
been reached only with high concentrations. For example, 
the extract of C. erythroxyloides leaves, the most active 
against cancer cell lines, reaches an GI50 higher than 250 
μg.mL-1 for the VERO cell line. 
 On the other hand, extract of stems of C. 
splendidus had the lowest inhibition potential (mean of 
log GI50=1.64), while all other six extracts presented at 
least a weak antiproliferative activity (mean of log GI50 
from 1.20 to 1.48) (Table 1). Among leaf extracts, C. 
dichrous extract showed a slightly selectivity for MCF-7 
(breast, GI50=16.07 μg.mL-1) cell line, C. splendidus 
extract presented some selectivity against H460 (lung, 
GI50=6.08 μg.mL-1) and K562 (leukemia, GI50=8.00 
μg.mL-1) cell lines, while C. myrianthus was even more 
selective for MCF-7 (breast, GI50=1.29 μg.mL-1) and 
U251 (glioma, GI50=1.34 μg.mL-1) cell lines. Looking at 
the stem extracts, C. dichrous extract showed selectivity 
for K562 (leukemia, GI50=2.11 μg.mL-1) and OVCAR-3 
(ovarian, GI50=9.00 μg.mL-1) cell line, C. myrianthus was 
more selective for U251 (glioma, GI50=3.34 μg.mL-1), 
K562 (leukemia, GI50=4.05 μg.mL-1), MCF-7 (breast, 
GI50=4.19 μg.mL-1) and OVCAR-3 (ovarian, GI50=6.60 
μg.mL-1) cell lines, and C. erythroxyloides extract presented 
some selectivity against K562 (leukemia, GI50=7.48 
μg.mL-1), U251 (glioma, GI50=8.51 μg.mL-1) and PC-3 
(prostate, GI50=9.28 μg.mL-1) cell lines.
 Manthey & Guthrie (2002) proposed that the 
activity of extracts with GI50 values lower than 10 μg.mL-1 
should be regarded as strong. Considering this new 
perspective, only two extracts, naming the leaf extract of 
C. dichrous and the stem extract of C. splendidus, showed 
no significant activity against the cell strains analyzed 
(Table 1). The stem extract of C. myrianthus also provided 
promising results toward four cell lines (U251, glioma; 
MCF-7, breast; OVCAR-3, ovary; K562, leukemia). Five 
of the eight extracts tested showed antiproliferative activity 
against K562 (leukemia). Notwithstanding, no extract 
presented considerable activity against strains UACC-62 
(glioma), ADR/RES (resistant ovarian), 786-0 (kidney) 
and HT-29 (lung) (Table 1).
 All methanol extracts were submitted to 
HPLC and GC/MS analysis. Table 2 shows the major 
compounds identified. Major compounds detected by 
HPLC analysis were flavonoids. Apigenin dihexoside was 
detected in leaf extracts of C. dichrous, C. myrianthus 
and C. erithroxyloides and tiliroside (kaempferol-p-
coumaroylglucoside) was ubiquitous. These results 
suggest that these flavonoids are not key compounds 
accounting for the better antiproliferative effects of C. 
erythroxyloides, since they are present also in extracts 
with weak or no growth inhibition activity, sometimes in 
higher contents. In addition, C. dichrous, a species with 
no promising antiproliferative activity (Table 1), contains 
significant amounts of these flavonoids. 
 Apigenin glycosides from chamomile 
(Matricaria chamomilla L.) have been reported as having 
antiproliferative activity, but much lower in comparison 
with the corresponding aglycone (Srivastava & Gupta, 
2007). 
 A study conducted with flavonoids from Citrus 
demonstrated loss of antiproliferative activity by different 
aglycones when they were glycosylated (Manthey & 
Guthrie, 2002). However, Rao et al. (2007) demonstrated 
a potent activity of tiliroside against Jurkat (lymphocytic 
leukemia) and HepG2 (hepatoma) cancer cell lines. 
Interestingly, for the leukemia K562 lineage, used in our 
study, there seems to be a correlation between tiliroside 
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Table 1. Extract concentration (μg.mL-1) needed to 50% of growth inhibition of human cancer cell lines.
content and antiproliferative activity (Table 1). Most stem 
extracts have over 50% of tiliroside and moderate activity 
against K562 cell line (Table 2 ). Even C. splendidus, with 
lower tiliroside content, inhibited the growth of this cell line 
at a moderate rate. The leaf extract of C. erythroxyloides 
had the highest activity toward leukemia line (GI50=1.86 
μg.mL-1; Table 1) and the highest concentration of tiliroside 
(Table 2). A test of the activity of tiliroside against K562 
cells would be interesting. 
 Vitexin appears only in the leaves of C. 
splendidus, which has moderate activity against K562 (log 
GI50=0.90) and H460 (log GI50=0.78). This compound 
was isolated from a medicinal plant from cerrado, Luehea 
candicans, Tiliaceae, which showed antiproliferative 
activity against various cell lines, including K562 (Silva 
et al., 2012).
 The GC/MS analysis unveiled the triterpene 
lupeol in extracts of C. erythroxyloides. As mentioned 
before, only these extracts showed moderate 
antiproliferative activity based on NCI criteria (Table 
1). In fact, antitumor activity of lupeol has been 
demonstrated against several cancer lines, including 
ovarian (Chaturvedula et al., 2004) and prostate (Prasad 
et al., 2005). The stem extract of the same species also 
contains lupeol, although in smaller amounts than 
in leaves. Nevertheless, its activity against PC-3 is 
moderate (log GI50=0.97) and higher than the activities 
of stem extracts from other species.
 On the other hand, β-sitosterol was detected in 
five extracts and, besides its known effect at treatment 
of benign prostate hyperplasia (Scholtysek et al., 
2009), no clear correlation was noted between the 
presence of β-sitosterol in analyzed Croton species and 
antiproliferative activity against PC-3. 
 Among the leaf and stem extracts of the four 
studied species of Croton, the leaf extract of Croton 
erythroxyloides seems to be a promising source of 
substances against at least two different cancer cell lines 
with the additional benefit of exhibiting low activity 
against normal cells. This finding turns C. erythroxyloides 
a strong candidate for further in-depth studies about 
antiproliferative activity.
Samples
Cell linesa Mean log 
GI50bVERO U251 UACC-62 MCF-7 ADR/RES 786-0 H460 PC-3 OVCAR-3 HT-29 K562
Doxorubicinc 0.66 0.025 0.028 0.14 0.093 0.034 <0.025 0.052 0.12 0.033 0.054 -1.31 P
Leaf extracts
C. dichrous 26.43 26.86 22.21 16.07 23.38 60.9 28.72 25.06 27.95 79.63 26.5 1.48 W
C. erythroxyloides >250 5.32 24.42 17.49 11.66 87.82 174.31 0.80 0.81 21.95 1.86 1.00 M
C. myrianthus 93.37 2.34 44.06 1.29 14.21 31.47 29.59 29.13 10.67 56.15 29.13 1.20 W
C. splendidus 88.03 27.6 26.36 25.32 26.05 30.03 6.08 28.79 28.65 40.35 8.00 1.34 W
Stem extracts
C. dichrous >250 24.83 34.38 17.49 10.05 93.78 33.78 35.71 9.00 82.76 2.11 1.34 W
C. erythroxyloides 191.2 8.51 25.44 29.88 23.36 49.14 16.08 9.28 20.44 64.64 7.48 1.30 W
C. myrianthus >250 3.34 31.24 4.19 27.36 191.7 212.56 13.88 6.66 27.95 4.05 1.27 W
C. splendidus 133.9 10.25 30.03 69.67 28.3 143.9 49.48 55.87 45.38 199.8 11.06 1.64 I
Table 2. Main compounds from methanol leaf and steam extracts of four species of Croton. The values corresponde to percentage 
amounts at each extract.
aCell lines: VERO: kidney epithelial cells of African green monkey (normal cells - control); U251: glioma; UACC-62: melanoma; MCF-7: 
mammary; ADR/RES: drug resistant ovary; 786-0: kidney; H460:lung; PC-3: prostate; OVCAR-3: ovary; HT-29: colon; K562: leukemia. bNational 
Cancer Institute criteria (Fouche et al., 2008): I: inactive, mean log GI50>1.5; W: week activity, mean log GI50>1.10-1.5; M: moderate activity, 
mean log GI50>0-1.1; P: potent activity, mean log GI50<0. cPositive control.
Rt (min) Compounds
C. dichrous C. erythroxyloides C. myrianthus C. splendidus
L S L S L S L S
GC analysis
22.10 β-sitosterol 9.8 22.6 9.1 7.8 6.9 8.2
22.77 lupeol 30.6 8.0
HLPC analysis
15.20 apigenin dihexoside 7.5 12.3 15.3
20.60 vitexin 31.9
41.49 tiliroside 14.0 56.6 37.7 59.0 27.3 72.5 8.6 38.1
Rt: retention time; L: leaf extract; S: steam extract.
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